Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Acetoacetic acid sodium salt is a metabolite of non-esterified fatty acids, involved in the development of human diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
2 mg | In stock | $ 59.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 147.00 | |
25 mg | In stock | $ 240.00 | |
50 mg | In stock | $ 360.00 | |
100 mg | In stock | $ 535.00 | |
500 mg | In stock | $ 1,160.00 |
Description | Acetoacetic acid sodium salt is a metabolite of non-esterified fatty acids, involved in the development of human diabetes. |
In vitro | Acetoacetic acid sodium salt triggers oxidative stress, thereby impeding very-low-density lipoprotein (VLDL) assembly in bovine hepatocytes. This compound, at concentrations of 0.6, 2.4, and 4.8 mM, increases malondialdehyde (MDA) content in the high-dose group (GH), diminishes mRNA levels of Mn-SOD, Cu/Zn SOD, and glutathione peroxidase (GSH-Px) across all groups, and reduces catalase (CAT) mRNA expression in the medial-dose (GM) and GH groups. Furthermore, it suppresses mRNA expression of apolipoprotein B100 (ApoB100), apolipoprotein E (ApoE), and the low-density lipoprotein receptor (LDLR), leading to reduced VLDL assembly and heightened triglyceride (TG) accumulation in bovine hepatocytes. |
Molecular Weight | 124.07 |
Formula | C4H5NaO3 |
CAS No. | 623-58-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (403.00 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Acetoacetic acid sodium salt 623-58-5 Others inhibit Endogenous Metabolite Acetoacetic acid sodium Inhibitor Acetoacetic acid inhibitor